Mesenchymal stem cells improve ovarian function by suppressing fibrosis through CTGF/FAK signalling in systemic lupus erythematosus
Objective SLE is a multisystem autoimmune disease characterised by chronic inflammation and progressive organ damage, including ovarian dysfunction. This study investigated the therapeutic efficacy of umbilical cord-derived mesenchymal stem cells (UC-MSCs) in ameliorating ovarian impairment and rest...
Saved in:
| Main Authors: | Min Xu, Hui Yang, Lingyun Sun, Hongwei Chen, Yueyang Zhang, Haiwei Zhang, Yingyi Wu, Yirui Shi |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2025-08-01
|
| Series: | Lupus Science and Medicine |
| Online Access: | https://lupus.bmj.com/content/12/2/e001468.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Clinical Efficacy and Safety of Mesenchymal Stem Cells for Systemic Lupus Erythematosus
by: Tianbiao Zhou, et al.
Published: (2020-01-01) -
RhoA determines lineage fate of mesenchymal stem cells by modulating CTGF–VEGF complex in extracellular matrix
by: Changjun Li, et al.
Published: (2016-04-01) -
Gene Expression Profile Reveals Abnormalities of Multiple Signaling Pathways in Mesenchymal Stem Cell Derived from Patients with Systemic Lupus Erythematosus
by: Yu Tang, et al.
Published: (2012-01-01) -
Double Allogenic Mesenchymal Stem Cells Transplantations Could Not
Enhance Therapeutic Effect Compared with Single Transplantation in Systemic Lupus Erythematosus
by: Dandan Wang, et al.
Published: (2012-01-01) -
Author Correction: RhoA determines lineage fate of mesenchymal stem cells by modulating CTGF–VEGF complex in extracellular matrix
by: Changjun Li, et al.
Published: (2025-07-01)